CSR Analysis Axoltis Pharma
axoltis.comDevelopment of innovative drugs for neurological disorders, focusing on blood-brain barrier restoration, neuroprotection, and enhanced neurotransmission.
E
CSR Analysis score
The organization does not position itself on any CSR axis.
EmpCo Directive — September 27, 2026
Greenwashing: does Axoltis Pharma's communication contain risky green claims?
We analyzed the websites of over 250,000 companies, including Axoltis Pharma's, to extract CSR initiatives and communications containing risky environmental claims.
Greenwashing risk score + your position within your sector
Sector data Industrie pharmaceutique et biotechnologies
8,585CSR initiatives analyzed in sector Industrie pharmaceutique et biotechnologies
2,292Companies in sector Industrie pharmaceutique et biotechnologies
1,237SMEs (10 to 250 employees) in sector Industrie pharmaceutique et biotechnologies
+250,000
Total organizations analyzedDiscover our sector reports
Detailed analysis by theme
Analysis by axis
Discover the complete analysis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
How are these scores calculated?
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: January 2026
They trust us
